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Purpose/Objective: Oral cavity (OC) is an important organ at risk (OAR) to keep in mind when planning radiotherapy treatment in locally advanced head and neck cancer patients. The quality of life in these patients can be diminished because of the mucositis profile, reducing the tolerance and efficacy of the therapy. Lowering the D mean and D max constraints to the OC without compromise the prescribe dose to the PTV can be achieved helping to decrease the risk of sever mucositis (Figure 1 ). There are no consensuses that demonstrate a better way of contour the OC as OAR. The objective of this study is to investigate how the method we used to contour the OC influences on dosimetry without compromising the treatment compliance and reduces the risk of severe mucositis. Figure 1 . Oropharyngeal mucositis secondary to chemoradiotherapy without contouring OC as OAR.
Materials and Methods:
Nineteen patients with locally advance head and neck cancer treated with Intensity Modulated Radiotherapy (IMRT) techniques were analysed in this study. Treatment was designed according to international recommendations utilising IMRT technique with 7 fields and dynamic multileaf collimator, delivering dose between 66 and 70 Gy to the PTV. The Monaco treatment planning system with Monte Carlo algorithm was used. The same physician made the contouring of the PTV volume and the OC. The oral cavity included: hard palate mucosa, floor of the mouth, orbicular muscle and lips, upper and lower teeth and gingiva, oral vestibule and the ventral 2/3 portion of the tongue.Patients were followed weekly by the physician recording and classifying the grade of mucositis in two groups, group A: asymptomatic or mild ulcers and group B: severe ulcers or mayor bleeding pseudo membrane. Oral cavity D mean, D max, V50Gy, V45Gy, V40Gy, V35Gy, V30Gy, V25Gy and V20Gy were recorded and compared. We used a standard statistical analysis to describe the D mean, D max and volumes with the grade of mucositis appearance. We have compared our results with similar published series. Results: The PTV median prescribed dose was 67Gy (range: 66-70Gy) without losing tighter values of D max: 38.3Gy (range: 32-52) and D mean: 18Gy (range: 10-26Gy). In the group A, 15 patients (78.9%) were assessed with mucositis toxicity grade ≤2 and in-group B, only 4 patients (21%) reached a mucositis toxicity grade ≥3 with no severe complications. In the 19 cases the OC volumes mean was 96.4cc accomplishing lower doses in the oral cavity has an organ at risk. We also evaluated the V20, V25, V30, V45 and V50 of the OC. ( Conclusions: This descriptive study shows contouring the OC in a tighter way can be achieved without risking PTV dose prescribe, the D mean and D max. Also features lesser D max D mean in the OC comparing the publications available, reaching more restrictive constrains dose and lowering sever mucositis presentation. More research is needed to compare different methods to contour the oral cavity to obtain a lower mucositis profile.
